ORGANIC
LETTERS
2007
Vol. 9, No. 21
4235-4238
Divergent Synthesis of Cytotoxic Styryl
Lactones from -Xylose. The First Total
Synthesis of ( )-Crassalactone C
D
+
Velimir Popsavin,*,† Goran Benedekovic´,† Bojana Srec´o,† Mirjana Popsavin,†
Jovana Francuz,† Vesna Kojic´,‡ and Gordana Bogdanovic´‡
Department of Chemistry, Faculty of Sciences, UniVersity of NoVi Sad,
Trg D. ObradoVic´a 3, 21000 NoVi Sad, Serbia, and Institute of Oncology Sremska
Kamenica, Institutski put 4, 21204 Sremska Kamenica, Serbia
Received July 26, 2007
ABSTRACT
A new divergent approach to (
+
)-goniofufurone (1) and 7-epi-(+)-goniofufurone (2), as well as the first total synthesis of crassalactone C (3),
has been achieved starting from
D-xylose. In a preliminary bioassay, all three natural products 1, 2, and 3 showed remarkable in vitro
antiproliferative activities against K562, Raji, and HeLa neoplastic cell lines.
Asian trees of the genus Goniothalamus of the plant family
Annonaceae have long been recognized as a source of
biologically active styryl lactones.1 Many styryl lactones that
have been isolated from Goniothalamus species or synthe-
sized exhibited a notable cytotoxic activity against certain
human tumor cell lines.2 (+)-Goniofufurone (1) and 7-epi-
(+)-goniofufurone3 (2) are naturally occurring styryl lactones
that have attracted considerable attention since their isolation
from the stem bark of Goniothalamus giganteus (Annon-
aceae).4,5 Due to their unique structural features and promis-
ing antitumor activities, both natural products 1 and 2, along
with a number of their analogues, have been the targets of
many total syntheses.6,7 (+)-Crassalactone C (3) is a natural
7-O-cinnamoyl derivative of (+)-goniofufurone that was very
recently isolated from the leaves and twigs of Polyalthia
crassa.8 Its structure was determined on the basis of
spectroscopic methods. The absolute stereochemistry of 3
was established by treatment of the isolated (+)-1 with
cinnamoyl chloride. Apart from this nonselective and low-
yielding single step route,8 no total synthesis of 3 was hitherto
reported. As a part of our continuing interest in the synthesis
of natural products and analogues having γ-lactone rings,9
we have planned the synthesis of 1-3. We report herein their
† Department of Chemistry.
‡ Institute of Oncology.
(1) For a review on chemistry, biogenesis, and biological activities of
styryl lactones from Goniothalamus species, see: Blazquez, M. A.; Bermejo,
A.; Zafra-Polo, M. C.; Cortes, D. Phytochem. Anal. 1999, 10, 161.
(2) For recent reviews on cytotoxicity of styryl lactones and their
analogues, see: (a) de Fatima, A.; Modolo, L. V.; Conegero, L. S.; Pilli,
R. A.; Ferreira, C. V.; Kohn, L. K.; de Carvalho, J. E. Curr. Med. Chem.
2006, 13, 3371. (b) Mereyala, H. B.; Joe, M. Curr. Med. Chem. Anti-Cancer
Agents 2001, 1, 293. (c) See also ref. 1
(3) Due to differences in numbering systems, compound 2 is sometimes
named as 8-epi-goniofufurone (e.g., see ref 8).
(4) Fang, X. P.; Anderson, J. E.; Chang, C. J.; Fanwick, P. E.;
McLaughlin, J. L. J. Chem. Soc., Perkin Trans. 1 1990, 1655.
(5) Fang, X. P.; Anderson, J. E.; Chang, C. J.; McLaughlin, J. L.;
Fanwick, P. E. J. Nat. Prod. 1991, 54, 1034.
(6) For recent reviews on syntheses of styryl lactones, see: (a) Mondon,
M.; Gesson, J.-P. Curr. Org. Synth. 2006, 3, 41. (b) Zhao, G.; Wu, B.; Wu,
X. Y.; Zhang, Y. Z. Mini-ReV. Org. Chem. 2005, 2, 333.
(7) (a) Sartillo-Melendez, C.; Cruz-Gregorio, S.; Quintero, L.; Sartillo-
Piscil, F. Lett. Org. Chem. 2006, 3, 504. (b) Mihovilovic, M. D.; Bianchi,
D. A.; Rudroff, F. Chem. Commun. 2006, 3214. (c) Ferna´ndez de la Pradilla,
R.; Ferna´ndez, J.; Viso, A.; Ferna´ndez, J.; Go´mez, A. Heterocycles 2006,
68, 1579. (d) Prasad, K. R.; Gholap, S. L. Synlett 2005, 2260. (e) Ruiz, P.;
Murga, J.; Carda, M.; Marco, J. A. J. Org. Chem. 2005, 70, 713.
(8) Tuchinda, P.; Munyoo, B.; Pohmakotr, M.; Thinapong, P.; Sophasan,
S.; Santisuk, T.; Reutrakul, V. J. Nat. Prod. 2006, 69, 1728.
10.1021/ol701734s CCC: $37.00
© 2007 American Chemical Society
Published on Web 09/15/2007